Koers Lexagene Holdings Inc Toronto S.E.
Aandelen
WEY
CA52886L1031
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01-03-18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24-03-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18-06-18 |
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Tom Slezak
BRD | Director/Board Member | - | 12-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-41,65% | 7,83 mld. | |
-4,92% | 2,26 mld. | |
-26,94% | 1,84 mld. | |
-22,72% | 1,63 mld. | |
+4,43% | 922 mln. | |
+24,17% | 803 mln. | |
-8,73% | 703 mln. | |
-31,22% | 531 mln. | |
-5,77% | 283 mln. |